AFST

(redirected from Antifungal Susceptibility Testing)
AcronymDefinition
AFSTAntifungal Susceptibility Testing
AFSTAssociation of Food Scientists and Technologists (India)
AFSTAssociation of Fire Science Technicians
AFSTAugmented Fire Support Terminal
AFSTAdaptive Fusion Steiner Tree (computing)
AFSTAir Force Special Tactics
AFSTArthur Fluid System Technologies (Texas)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST.
Antifungal susceptibility testing: Clinical Laboratory and Standards institute (CLSI) Methods.
Isolation, Speciation and Antifungal Susceptibility Testing of Candida from Clinical Specimens at a Tertiary Care Hospital.
All the Candida aibicans were subjected for antifungal susceptibility testing and 68 of them were found to be resistant to all antifungal agents (Fig.
Process analysis of variables for standardization of antifungal susceptibility testing of nonfermentative yeasts.
Antifungal susceptibility testing of various Candida species showed that all isolates were susceptible to amphotericin B.
[24] Clinical and Laboratory Standards Institute, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard, Clinical and Laboratory Standards Institute, Wayne, PA, USA, 2nd edition, 2008.
Antifungal susceptibility testing was performed with AST YS07 kits on VITEK 2 compact.
All isolates of Candida were characterized and subjected to antifungal susceptibility testing using the Vitek 2 system.
The isolate then was transferred to the provincial public health laboratory (Laboratoire de sante publique du Quebec [LSPQ]) for species identification, molecular typing, and antifungal susceptibility testing. It was confirmed as Cryptococcus gattii by melanin production on bird seed agar media and by the production of a blue color on Canavanine-GlycineBromothymol blue (CGB) media.
Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing. Clin Microbiol Rev Apr 2006;19(2):435-47.
The in vitro antifungal susceptibility testing was performed by broth microdilution according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) reference method.[sup][16] Itraconazole, voriconazole, and posaconazole were diluted to the required concentrations in RPMI with 2% of glucose stock solutions.